Endometrial Ablation Market Size, Share, Industry Trends and Forecast to 2030

Market Size & CAGR of Endometrial Ablation Market in 2021

The global endometrial ablation market is expected to witness a Compound Annual Growth Rate (CAGR) of 5.7% from 2021 to 2028, reaching a market size of USD 1.25 billion by the end of the forecast period. The increasing prevalence of gynecological disorders and the rising adoption of minimally invasive procedures are driving the growth of the endometrial ablation market.

COVID-19 Impact on the Endometrial Ablation Market

The COVID-19 pandemic had a significant impact on the endometrial ablation market. Due to the restrictions on elective procedures and the reallocation of healthcare resources to manage the pandemic, there was a decline in the number of endometrial ablation procedures performed in 2020. However, as healthcare systems stabilized and adapted to the new normal, the market witnessed a rebound in demand for endometrial ablation procedures in 2021.

Endometrial Ablation Dynamics

Endometrial ablation is a minimally invasive procedure used to treat abnormal uterine bleeding in women. It involves the destruction or removal of the endometrial lining of the uterus, which helps alleviate heavy menstrual bleeding. The global endometrial ablation market is driven by factors such as the increasing prevalence of gynecological disorders, advancements in ablation technologies, and the growing acceptance of minimally invasive procedures among patients and healthcare providers.

Segments and Related Analysis

The endometrial ablation market can be segmented based on technology, end-user, and region. By technology, the market is divided into radiofrequency ablation, microwave ablation, cryoablation, hydrothermal ablation, and others. By end-user, the market is categorized into hospitals, ambulatory surgical centers, and gynecology clinics. Regionally, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

By Region Analysis

- North America: The North American region dominates the global endometrial ablation market due to the presence of advanced healthcare infrastructure and a high prevalence of gynecological disorders.

- Europe: Europe is expected to witness significant growth in the endometrial ablation market, driven by increasing healthcare expenditures and rising awareness about minimally invasive procedures.

- Asia Pacific: The Asia Pacific region is projected to experience rapid market growth due to the increasing adoption of advanced medical technologies and a growing geriatric population.

- Latin America: Latin America is poised for steady growth in the endometrial ablation market, supported by improving healthcare infrastructure and the rising prevalence of uterine abnormalities.

- Middle East & Africa: The Middle East & Africa region is expected to witness a gradual increase in market demand due to improving access to healthcare services and rising awareness about gynecological treatments.

Key Market Players and Competitive Landscape

The key players in the global endometrial ablation market include Hologic Inc., Boston Scientific Corporation, Medtronic plc, CooperSurgical Inc., Olympus Corporation, Minerva Surgical Inc., AngioDynamics Inc., Smith & Nephew plc, The Cooper Companies Inc., and others. These companies are focusing on product innovations, strategic collaborations, and acquisitions to strengthen their market presence and expand their product portfolios.

Recent Happenings in the Endometrial Ablation Market

- In March 2021, Hologic Inc. launched the Acessa Health division to focus on the development of minimally invasive solutions for uterine fibroids and other gynecological conditions.

- In July 2021, Boston Scientific Corporation announced the acquisition of Devoro Medical, a medical device company specializing in minimally invasive treatments for various gynecological conditions, including endometrial ablation.

- In September 2021, Medtronic plc introduced the Emprint Ablation System for the treatment of benign and malignant tumors, including uterine fibroids, using microwave ablation technology.

- In January 2022, CooperSurgical Inc. received FDA approval for its new endometrial ablation device, expanding its product offerings in the gynecological treatment market.